Obesity and metabolic abnormalities as risks of alcoholic fatty liver in men: NAGALA study
Open Access
- 9 August 2021
- journal article
- research article
- Published by Springer Nature in BMC Gastroenterology
- Vol. 21 (1) , 1-9
Abstract
Background: Hepatic steatosis has a pivotal role in the development of chronic liver diseases, even in alcohol-related liver disease. Alcoholic fatty liver disease is an important phenotype among alcohol-related liver diseases. While metabolic syndrome is a dominant risk factor of incident nonalcoholic fatty liver disease, the role of metabolic syndrome in alcoholic fatty liver disease has not been clarified yet. Methods: A retrospective cohort study was performed at a health check-up center in Japan. Subjects consisted of male participants without fatty liver who consumed ethanol of 420 g/week or higher. Adjusted hazard ratios and 95% confidence intervals at the baseline examinations for incident alcoholic fatty liver disease were estimated using Cox model. Results: A total of 640 participants were included in this study. During 3.91 years (IQR 1.63–7.09) of follow-up, 168 new cases of alcoholic fatty liver disease developed (49.1 cases per 1000 persons per year). After adjustment for age, smoking status, alcohol consumption, the hazard ratio for a 1 kg/m2 increase in body mass index was 1.2 (1.12–1.28). The hazard ratio of subjects with high triglyceride and low high-density lipoprotein-cholesterol levels were 1.56 (1.12–2.18) and 1.52 (1.03–2.25), respectively. Conclusions: Obesity, high triglyceridemia, and low high-density lipoprotein-cholesterolemia are independent risk factors of alcoholic fatty liver disease in Japanese men who consumed alcohol habitually. In people with these risks, triglyceride lowering and high-density lipoprotein-cholesterol raising by improving insulin resistance and weight maintenance in addition to abstinence from alcohol would be effective in preventing the development of alcoholic fatty liver disease.Keywords
This publication has 43 references indexed in Scilit:
- Cirrhosis and mortality risks of biopsy‐verified alcoholic pure steatosis and steatohepatitis: a nationwide registry‐based studyAlimentary Pharmacology & Therapeutics, 2012
- Identification of individuals with non-alcoholic fatty liver disease by the diagnostic criteria for the metabolic syndromeWorld Journal of Gastroenterology, 2012
- The relationship between body mass index and the variation in plasma levels of triglycerides after short-term red wine consumptionJournal of Clinical Lipidology, 2011
- Systematic review: the epidemiology and natural history of non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitis in adultsAlimentary Pharmacology & Therapeutics, 2011
- Nuclear Receptors in Liver Disease ΔHepatology, 2011
- Components of metabolic syndrome are independent predictors of mortality in patients with chronic liver disease: a population-based studyGut, 2010
- Fatty Liver Is Independently Associated With Alterations in Circulating HDL2 and HDL3 SubfractionsDiabetes Care, 2008
- Steatosis: Co-factor in Other Liver Diseases *Hepatology, 2005
- Hepatic steatosis is a risk factor for hepatocellular carcinoma in patients with chronic hepatitis C virus infectionCancer, 2003
- Ethanol Induces Fatty Acid Synthesis Pathways by Activation of Sterol Regulatory Element-binding Protein (SREBP)Journal of Biological Chemistry, 2002